Research is being conducted on the use of ex vivo drug sensitivity profiling to improve precision oncology, particularly in pediatric cases. Studies have explored the integration of this approach with molecular profiling to better understand cancer treatment outcomes. The application of ex vivo technology is being investigated across various types of cancer, with some studies suggesting its potential to guide personalized chemotherapy and improve disease-free survival.